Inhibition of CCL19 benefits non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB-p65 signaling.
| Autor: | Zhao, Jiajing1 zhaojiajingrose@126.com, Wang, Yingjue1, Wu, Xi2, Tong, Ping3, Yue, Yaohan1, Gao, Shurong1, Huang, Dongping4, Huang, Jianwei4 huangjianwei1124@live.cn |
|---|---|
| Zdroj: | Molecular Medicine Reports. Nov2018, Vol. 18 Issue 5, p4635-4642. 8p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|